Lidokainklorid B. Braun (Lidocaine Hydrochloride)

Lidocaine hydrochloride blocks voltage‑gated sodium channels on nerve membranes, stabilising them in an inactive state. This prevents the rapid influx of sodium ions needed for depolarisation, thereby inhibiting the generation and propagation of nerve impulses and producing a localized anesthetic effect.

The appropriate dose of Lidokainklorid B. Braun is determined by the prescribing clinician based on the specific procedure, patient characteristics, and desired level of anesthesia. Healthcare professionals calculate the volume and concentration required to achieve safe and effective epidural analgesia.

Safety data for lidocaine hydrochloride in pregnancy and lactation are limited. It may be used when the potential benefit justifies the potential risk to the fetus or infant, but clinicians should evaluate each case individually and follow local regulatory guidance.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Lidokainklorid B. Braun contains lidocaine, an amide‑type local anesthetic with a rapid onset and intermediate duration of action. Compared with bupivacaine, lidocaine has a shorter duration but a lower risk of cardiotoxicity at equivalent doses, making it suitable for procedures requiring quicker recovery of sensation.

The product should be stored below 25 °C in its original packaging, protected from light and moisture. Do not freeze the solution. Before use, inspect the vial for particulate matter or discoloration and ensure aseptic technique during epidural administration.

Lidokainklorid B. Braun is administered by a qualified healthcare professional via epidural injection. The sterile solution is injected into the epidural space using a catheter or needle under aseptic conditions, with the dose adjusted to achieve the desired level of sensory block while monitoring the patient closely.

Serious risks include central nervous system toxicity such as seizures, cardiovascular complications like arrhythmias or cardiac arrest, severe allergic reactions (anaphylaxis), and rare cases of methemoglobinemia. Prompt recognition and management of these events are essential during and after administration.

Patients with a known hypersensitivity to lidocaine or other amide‑type local anesthetics, those with severe heart block, uncontrolled epilepsy, or significant hepatic impairment should avoid this product. Clinicians must also exercise caution in patients with low plasma protein levels or concurrent use of drugs that affect lidocaine metabolism.